ArticleExperimental hematology & oncology2026
Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma.
Callee Brooks et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.